Business
Why the Mesoblast share price jumped higher this morning – Motley Fool Australia
Today the Mesoblast share price jumped higher after the company announced a positive recommendation regarding its COVID-19 treatment trials.
This morning, the Mesoblast limited(ASX: MSB) share price jumped 3.14% to $5.25 after the company received a positive recommendation from the Data Safety Monitoring Board (DSMB) to continue its phase 3 trial of remestemcel-L in patients with acute COVID-19. The positive news, however, was not sufficient to sustain the Mesoblast share price amid wider share market falls with the company now trading at $5.04 at the time of writing.
What moved the Mesoblast share price?
The Mesoblast share pric…
-
Noosa News22 hours agoRallies under way as nationwide support for Palestine surges
-
Noosa News21 hours agoSkybound Gymnastics owner and coach Wei Jun Lee charged with sexual assault of teenager
-
General24 hours agoNRL live updates: Newcastle Knights vs Brisbane Broncos, Wests Tigers vs North Queensland Cowboys — blog, scores and stats
-
General19 hours agoThousands flood cities demanding action on Palestine